Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers

Abroad (travel likely)RecruitingPHASE2

Conditions

Unresectable Pancreatic Cancer · Unresectable Bile Duct Carcinoma · Unresectable Biliary Tract Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,, Goyang-si, Gyeonggi-do, South Korea
Contact: Study coordinator (SANGMYUNG WOO, MD) · wsm@ncc.re.kr · 82-31-920-1733

Study leads

Sangmyung Woo, M.D
Principal Investigator
National Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Non-small Cell Lung Cancer · Advanced Pancreatic Adenocarcinoma · Unresectable Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Boston, United States · Boston, United States

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Advanced Solid Tumors With KRAS G12C Mutations · Solid Tumor, Adult · Unresectable Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

La Jolla, United States · Orange, United States

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Jacksonville, United States · Warrenville, United States

First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients

Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Shanghai, China